{"count": 21, "results": [{"_id": "37438479", "pmid": 37438479, "title": "Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.", "journal": "Sci Rep", "authors": ["Cserne Szappanos H", "Viola HM", "Ito DW", "Lim S", "Mangala M", "Holliday M", "Barratt Ross S", "Semsarian C", "Hill A", "Dixon RE", "Hool LC"], "date": "2023-07-12T00:00:00Z", "doi": "10.1038/s41598-023-38296-2", "meta_date_publication": "2023 Jul 12", "meta_volume": "13", "meta_issue": "1", "meta_pages": "11296", "score": 50232.81, "text_hl": "Following in vivo administration of @CHEMICAL_Isoproterenol @CHEMICAL_MESH:D007545 @@@isoproterenol@@@, mutant mice exhibited @DISEASE_Tachycardia @DISEASE_MESH:D013610 @@@tachyarrhythmias@@@, poor recovery and @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@. @DISEASE_Arrhythmias_Cardiac @DISEASE_MESH:D001145 @@@Arrhythmias@@@ were attenuated with the beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and protein kinase A inhibitor PKI. ", "citations": {"NLM": "Cserne Szappanos H, Viola HM, Ito DW, Lim S, Mangala M, Holliday M, Barratt Ross S, Semsarian C, Hill A, Dixon RE, Hool LC. Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy. Sci Rep. 2023 Jul 12;13(1):11296. PMID: 37438479", "BibTeX": "@article{37438479, title={Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.}, author={Cserne Szappanos H and Viola HM and Ito DW and Lim S and Mangala M and Holliday M and Barratt Ross S and Semsarian C and Hill A and Dixon RE and Hool LC}, journal={Sci Rep}, volume={13}, number={1}, pages={11296}}"}}, {"_id": "7363686", "pmid": 7363686, "title": "Atenolol in hypertension: a cardioselective drug.", "journal": "Chest", "authors": ["Ezra D", "Molho M", "Rosenthal T"], "date": "1980-05-01T00:00:00Z", "doi": "10.1378/chest.77.5.662", "meta_date_publication": "1980 May", "meta_volume": "77", "meta_issue": "5", "meta_pages": "662-5", "score": 50067.566, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@: a cardioselective drug.", "citations": {"NLM": "Ezra D, Molho M, Rosenthal T. Atenolol in hypertension: a cardioselective drug. Chest. 1980 May;77(5):662-5. PMID: 7363686", "BibTeX": "@article{7363686, title={Atenolol in hypertension: a cardioselective drug.}, author={Ezra D and Molho M and Rosenthal T}, journal={Chest}, volume={77}, number={5}, pages={662-5}}"}}, {"_id": "17996", "pmid": 17996, "title": "Atenolol in the treatment of angina pectoris.", "journal": "Acta Med Scand", "authors": ["Erikssen J", "Osvik K", "Dedichen J"], "date": "1977-01-01T00:00:00Z", "doi": "10.1111/j.0954-6820.1977.tb15751.x", "meta_date_publication": "1977", "meta_volume": "201", "meta_issue": "6", "meta_pages": "579-84", "score": 50067.06, "text_hl": "Fifteen patients had subjective improvement on @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, two were unchanged and two felt worse (because of @DISEASE_Asthenia @DISEASE_MESH:D001247 @@@asthenia@@@/leg @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@). ", "citations": {"NLM": "Erikssen J, Osvik K, Dedichen J. Atenolol in the treatment of angina pectoris. Acta Med Scand. 1977;201(6):579-84. PMID: 17996", "BibTeX": "@article{17996, title={Atenolol in the treatment of angina pectoris.}, author={Erikssen J and Osvik K and Dedichen J}, journal={Acta Med Scand}, volume={201}, number={6}, pages={579-84}}"}}, {"_id": "973971", "pmid": 973971, "title": "Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.", "journal": "Br J Clin Pharmacol", "authors": ["Lund-Johansen P"], "date": "1976-06-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1976.tb00620.x", "meta_date_publication": "1976 Jun", "meta_volume": "3", "meta_issue": "3", "meta_pages": "445-51", "score": 50065.902, "text_hl": "The mean arterial pressure-heart rate product was reduced almost 40%. 5 Apart from temporary @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@muscular fatigue@@@ during the first weeks, no side-effects were seen. 6 @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ is an effective blood pressure lowering drug in mild and moderate @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, but the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@drop in blood pressure@@@ is associated with marked @DISEASE_Cardiac_Output_Low @DISEASE_MESH:D002303 @@@reduction in heart rate and cardiac output@@@ at rest as well as during exercise.", "citations": {"NLM": "Lund-Johansen P. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Br J Clin Pharmacol. 1976 Jun;3(3):445-51. PMID: 973971", "BibTeX": "@article{973971, title={Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.}, author={Lund-Johansen P}, journal={Br J Clin Pharmacol}, volume={3}, number={3}, pages={445-51}}"}}, {"_id": "2049246", "pmid": 2049246, "title": "Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.", "journal": "Br J Clin Pharmacol", "authors": ["Lewis RV", "Ramsay LE", "Jackson PR", "Yeo WW", "Lennard MS", "Tucker GT"], "date": "1991-04-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1991.tb05551.x", "meta_date_publication": "1991 Apr", "meta_volume": "31", "meta_issue": "4", "meta_pages": "391-8", "score": 50062.523, "text_hl": "Influence of @CHEMICAL_Debrisoquin @CHEMICAL_MESH:D003647 @@@debrisoquine@@@ oxidation phenotype on exercise tolerance and subjective @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@ after @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in healthy subjects.", "citations": {"NLM": "Lewis RV, Ramsay LE, Jackson PR, Yeo WW, Lennard MS, Tucker GT. Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects. Br J Clin Pharmacol. 1991 Apr;31(4):391-8. PMID: 2049246", "BibTeX": "@article{2049246, title={Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.}, author={Lewis RV and Ramsay LE and Jackson PR and Yeo WW and Lennard MS and Tucker GT}, journal={Br J Clin Pharmacol}, volume={31}, number={4}, pages={391-8}}"}}, {"_id": "3371390", "pmid": 3371390, "title": "Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.", "journal": "Eur J Clin Pharmacol", "authors": ["Blomqvist I", "Westergren G", "Sandberg A", "Jonsson UE", "Lundborg P"], "date": "1988-01-01T00:00:00Z", "doi": "10.1007/BF00578408", "meta_date_publication": "1988", "meta_volume": "33 Suppl", "meta_issue": "", "meta_pages": "S19-24", "score": 50060.586, "text_hl": "At this time the beta 1-blockade with metoprolol CR, 100 mg, was similar to that with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, 100 mg. At peak plasma concentrations, 4 h after the dose, the subjects experienced less @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@ during exercise with metoprolol CR than with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol. Eur J Clin Pharmacol. 1988;33 Suppl():S19-24. PMID: 3371390", "BibTeX": "@article{3371390, title={Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.}, author={Blomqvist I and Westergren G and Sandberg A and Jonsson UE and Lundborg P}, journal={Eur J Clin Pharmacol}, volume={33 Suppl}, pages={S19-24}}"}}, {"_id": "2675377", "pmid": 2675377, "title": "[Felodipine in arterial hypertension. Double-blind comparison with atenolol].", "journal": "Therapie", "authors": ["Andrejak M", "Witchitz S", "Morand P", "Lesbre JP", "Raveau-Landon C"], "date": "1989-05-01T00:00:00Z", "meta_date_publication": "1989 May-Jun", "meta_volume": "44", "meta_issue": "3", "meta_pages": "167-70", "score": 50057.54, "text_hl": "Supine blood pressure decreased from 177 +/- 22/107 +/- 8 mmHg to 152 +/- 27/91 +/- 13 mmHg with @CHEMICAL_Felodipine @CHEMICAL_MESH:D015736 @@@felodipine@@@ and from 176 +/- 19/107 +/- 8 to 152 +/- 24/91 +/- 12 with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. Side effects recorded by means of active questioning were @DISEASE_Ankle_Injuries @DISEASE_MESH:D016512 @@@ankle oedemas@@@ and @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ with @CHEMICAL_Felodipine @CHEMICAL_MESH:D015736 @@@felodipine@@@ and @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@ and @DISEASE_Headache @DISEASE_MESH:D006261 @@@headache@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Andrejak M, Witchitz S, Morand P, Lesbre JP, Raveau-Landon C. [Felodipine in arterial hypertension. Double-blind comparison with atenolol]. Therapie. 1989 May-Jun;44(3):167-70. PMID: 2675377", "BibTeX": "@article{2675377, title={[Felodipine in arterial hypertension. Double-blind comparison with atenolol].}, author={Andrejak M and Witchitz S and Morand P and Lesbre JP and Raveau-Landon C}, journal={Therapie}, volume={44}, number={3}, pages={167-70}}"}}, {"_id": "2373131", "pmid": 2373131, "title": "Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.", "journal": "Eur J Clin Pharmacol", "authors": ["Dimenäs ES", "Dahlöf CG", "Heibel B", "Moore RG", "Olofsson BK", "Westergren GE", "Lücker PW"], "date": "1990-01-01T00:00:00Z", "doi": "10.1007/BF00278584", "meta_date_publication": "1990", "meta_volume": "38", "meta_issue": "6", "meta_pages": "571-8", "score": 50055.41, "text_hl": "At the end of the dosage interval there was no longer any significant difference between the treatments. Perceived @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@leg fatigue@@@ during exercise, evaluated 4 h after dosing, was more pronounced during treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ than @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ CR 50 mg. ", "citations": {"NLM": "Dimenäs ES, Dahlöf CG, Heibel B, Moore RG, Olofsson BK, Westergren GE, Lücker PW. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol. Eur J Clin Pharmacol. 1990;38(6):571-8. PMID: 2373131", "BibTeX": "@article{2373131, title={Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.}, author={Dimenäs ES and Dahlöf CG and Heibel B and Moore RG and Olofsson BK and Westergren GE and Lücker PW}, journal={Eur J Clin Pharmacol}, volume={38}, number={6}, pages={571-8}}"}}, {"_id": "1671188", "pmid": 1671188, "title": "Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.", "journal": "Am Heart J", "authors": ["McLenachan JM", "Grant S", "Ford I", "Henderson E", "Dargie HJ"], "date": "1991-02-01T00:00:00Z", "doi": "10.1016/0002-8703(91)90448-q", "meta_date_publication": "1991 Feb", "meta_volume": "121", "meta_issue": "2 Pt 2", "meta_pages": "691-6", "score": 50055.375, "text_hl": "During the early stages of exercise, treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ was also associated with higher scores for the subjective indices of @DISEASE_Dyspnea @DISEASE_MESH:D004417 @@@breathlessness@@@ and @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@. ", "citations": {"NLM": "McLenachan JM, Grant S, Ford I, Henderson E, Dargie HJ. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II. Am Heart J. 1991 Feb;121(2 Pt 2):691-6. PMID: 1671188", "BibTeX": "@article{1671188, title={Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.}, author={McLenachan JM and Grant S and Ford I and Henderson E and Dargie HJ}, journal={Am Heart J}, volume={121}, number={2 Pt 2}, pages={691-6}}"}}, {"_id": "6142007", "pmid": 6142007, "title": "Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.", "journal": "Int J Clin Pharmacol Ther Toxicol", "authors": ["Lehtonen A", "Huupponen R", "Himanen P"], "date": "1984-02-01T00:00:00Z", "meta_date_publication": "1984 Feb", "meta_volume": "22", "meta_issue": "2", "meta_pages": "86-90", "score": 50052.43, "text_hl": "@CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@Carbohydrate@@@ and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism at rest and after 1 h submaximal physical exercise in cold weather (between -1 and -6 C) were studied in ten healthy male subjects treated in a randomized double-blind fashion for 2 days with either placebo, the non-selective beta-adrenoceptor antagonist with high ISA @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ (10 mg), or the cardioselective drug @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (100 mg). Four subjects, on both @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@, complained of @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@muscular fatigue@@@ during exercise on beta blockade; four other subjects perceived some @<m>DISEASE_Fatigue</m> @DISEASE_MESH:D005221 @@@fatigue@@@. ", "citations": {"NLM": "Lehtonen A, Huupponen R, Himanen P. Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather. Int J Clin Pharmacol Ther Toxicol. 1984 Feb;22(2):86-90. PMID: 6142007", "BibTeX": "@article{6142007, title={Effect of the short-term beta-adrenoceptor blockade on exercise metabolism in cold weather.}, author={Lehtonen A and Huupponen R and Himanen P}, journal={Int J Clin Pharmacol Ther Toxicol}, volume={22}, number={2}, pages={86-90}}"}}]}